Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw. Backed by 5AM Ventures.
About the role
Design and develop computational approaches for characterizing the performance of existing and new epigenomic tests. Define and implement metrics and analyses to assess NGS and epigenomic data quality to enable coordinated optimization of assay and diagnostic performance. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- PhD in computational biology, bioinformatics, biostatistics, or a closely related quantitative field. Direct experience with advanced NGS modalities (e.g., cell-free DNA, ChIP -Seq, or epigenomic signal processing) is highly preferred
- 4 –9 years of industry experience in regulated diagnostics, liquid biopsy, or IVD development, ideally within a fast-paced, cross-functional R&D environment
- Proven track record working under a formal Quality Management System (ISO 13485, 21 CFR Part 820)
- Hands-on experience contributing to regulatory submissions (such as Pre-Subs, De Novo, or 510(k) tracks). Please describe your specific role and submission type in your cover letter or CV
- Solid grasp of analytical validation frameworks , including CLSI EP guidelines, FDA IVD/CDx guidance, and CAP/CLIA requirements
- Fluency in R and/or Python for robust statistical modeling, dat a analysis, and reproducible reporting
More about this role
The Opportunity
We are seeking a Director -level computational scientist to drive the analytical and regulatory dimensions of diagnostic test development at Precede Biosciences. Reporting to the Senior Director of Computational Test Development, this role sits at the center of our effort to bring a novel epigenomics-based liquid biopsy platform from late-stage development through FDA regulatory submission.
You will lead the analytical strategy and bioinformatics infrastructure verification that underlies our validation programs. You will drive the interpretation of complex data, guide pipeline execution, and author critical regulatory documentation in close partnership with laboratory, clinical, and regulatory teams.
About Us
We are pioneering an advanced, minimally invasive, comprehensive epigenomics platform with the potential to profoundly impact the research and development of new medicines and the use of approved medicines in clinical practice across a number of conditions, including cancer. More information on our company and platform can be found on our company website and in our seminal publication in Nature Medicine.
We care deeply about creating a place where folks can...
Browse similar: Startup jobs